Dorset Formulary

	Dorset
	The Dorset Formulary has been developed in associations with NHS Dorset Clinical Commissioning Group Dorset County Hospital NHS Foundation Trust Dorset Healthcare University NHS Foundation Trust Poole Hospital NHS Foundation Trust Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust

Search

Formulary Chapter 13: Skin - Full Chapter

Notes:

Please note all items listed in the British Association of Dermatology specials list are classified as having a 'red' traffic light status except for Pigmanorm and Dundee sunscreen - please refer to individual entries for these items.

Chapter review date:

Chapter Links...

British Association of Dermatology (BAD) list of recommended special order products

Details...

13.08.01

Sunscreen preparations

Actinic Keratosis Pathway September 2017

13.08.01

Photodamage

Actikerall^®

Formulary

Solution, fluorouracil 0.5%, salicylic acid 10%

Not stocked at RBCH
DCHFT: Not routinely stocked.

Efudix^®

Formulary

Cream, fluorouracil 5%
Excipients include hydroxybenzoates (parabens), polysorbate 60, propylene glycol, stearyl alcohol

Ingenol mebutate gel (Picato^®)

Formulary

Use within the local guidance for Actinic Keratosis.

Gel, ingenol mebutate 150 micrograms/g
Excipients include benzyl alcohol

Not stocked at RBCH
DCHFT: Not routinely stocked.

Zyclara^®

Formulary

Cream, imiquimod 3.75%
DCHFT and RBCH: Not routinely stocked.

Aldara^®

Formulary

Cream, imiquimod 5%

Metvix^®

Formulary

Hospital use only
Methyl-5-Aminolevulinate
Used in photodyamic therapy

....

Non Formulary Items

Solaraze^®

Non Formulary

Gel, diclofenac sodium 3% in a sodium hyaluronate basis
Excipients include benzyl alcohol

Key

	Notes
	Section Title (top level)
	Section Title (sub level)
	First Choice item
	Non Formulary section
	Restricted Drug
	Unlicensed
	Display tracking information
	Link to adult BNF
	Link to children's BNF
	Link to SPCs

	Cytotoxic Drug
	Controlled Drug
	High Cost Medicine
	Cancer Drugs Fund
	NHS England
	Homecare
	CCG

Traffic Light Status Information

Status	Description
	May be initiated, stabilised and maintained in primary, secondary or tertiary care
	Amber drug - without shared care
	Amber drug - with shared care guideline
	For secondary or tertiary care initiation and long-term maintenance of prescribing
	Not recommended